Vident Advisory’s Pfizer PFE Stock Holding History

Vident Advisory's PFE Position: Q2 2026 in Review

Vident Advisory increased its Pfizer (PFE) stake by 51% in Q2 2026, buying an estimated $2.04M and bringing the position to 230,993 shares worth $5.56M. The position accounts for 0.04% of the portfolio, ranked #367.

Vident Advisory first reported a position in PFE in Q3 2023 and has held it in 10 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

• Vident Advisory held 230,993 shares of Pfizer worth $5.56M as of Q2 2026.
• Vident Advisory bought 78,119 Pfizer shares in Q2 2026, an estimated $2.04M.
• Pfizer made up 0.04% of Vident Advisory's portfolio in Q2 2026, its #367 holding.
• Vident Advisory first reported a position in Pfizer in Q3 2023 and has held it in 10 quarters since.
• 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.